Skip to main content
. 2021 Aug 27;13(9):1349. doi: 10.3390/pharmaceutics13091349

Figure 5.

Figure 5

Concentrations of CBD and triglyceride in lymph fluid. CBD was orally administered in sesame oil, Formulation 3 (F3, sesame oil:Tri-C8, 5:5, v/v) and Formulation 4 (F4, sesame oil:Tri-C8:Tween 85, 4:4:2, v/v/v with 10 mg/mL TPGS) at a dose of 25 mg/kg in rats (50 mg/mL CBD content in each formulation). (a) The concentration of CBD and triglyceride in lymph fluid at 1.5 h post-administration. (b) The concentration of CBD and triglyceride in lymph fluid at 2.5 h post-administration. All data are shown as mean ± SD, n = 4. Statistical analysis was performed using one-way ANOVA followed by Dunnett’s post-hoc test with sesame oil serving as a control group.